• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
    • Overview
    • Distribution by PR Newswire
    • Cision Communications Cloud®
    • Cision IR
    • All Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

The Galien Foundation Announces "Discovery of the Decade" Award Nominees in Best Pharmaceutical Product, Best Biotechnology Product, and Best Medical Technology Categories

Winners will be recognized by World Renowned Scientific Committee on October 27 at 10th Annual Prix Galien USA Awards Ceremony


News provided by

The Galien Foundation

Sep 27, 2016, 08:30 ET

Share this article

Share this article


NEW YORK, Sept. 27, 2016 /PRNewswire-USNewswire/ -- The Prix Galien Foundation announced today the Nominees for its "Discovery of the Decade" awards covering distinguished industry achievement in medical innovation. This once-in-10-years special recognition is being held under the sponsorship of the Foundation's Awards Committee, comprising of nine renowned leaders from academia and industry, including four Nobel Laureates. 

After 10 years of annual awards, the Prix Galien Awards Committee invited the awards winners to compete for the "Discovery of the Decade" awards which will honor their extraordinary human health impact for the three categories considered annually – Best Pharmaceutical Product, Best Biotech Product, and Best Medical Technology. The Discovery of the Decade awards winners will be announced at the 10th Annual Prix Galien USA Gala on Thursday, October 27, at the American Museum of Natural History in New York.

"The wonderful quality and broad diversity of medical innovations the Award Committee reviewed are the basis for the better outcomes of patients, illustrating that innovation is more exciting than ever," said P. Roy Vagelos, MD, chairman, Prix Galien USA Awards Committee and first recipient of the Foundation's Pro Bono Humanum Award for service in improving the human condition. "These extraordinary nominees demonstrate that great innovation translates into a brighter future for patients," he added.

Prix Galien USA is celebrating its 10th anniversary this year. Since the first Prix Galien USA awards in 2007, more than 250 new molecular entities [NMEs] have been approved by the Food and Drug Administration [FDA]. This year may surpass the record number of 45 novel drugs brought forward by the biopharmaceutical industry to patients in 2015. Additionally, the FDA has reviewed and approved for use scores of medical devices and technologies in cardiovascular disease, surgical care and diagnostics.

To acknowledge participating companies' quality submissions, the Awards Committee is considering 33 products honored previously since 2007, plus the 2016 Prix Galien USA laureates in each of its three selection categories.

 The Nominees are:  

Best Pharmaceutical Product Category

2015 – IMBRUVICA® (ibrutinib)

Janssen and Pharmacyclics LLC, an AbbVie Company

2014 – SOVALDI® (sofosbuvir) 

Gilead Sciences

2013 – ZELBORAF® (vemurafenib) 

Genentech

2011 – PREVNAR 13® Pneumococcal Vaccine 

Pfizer Inc.

2012 – INCIVEK® (Telaprevir) 

Vertex Pharmaceuticals  

2010 – COARTEM® (artemether/lumefantrine) 

Novartis

2009 – GLEEVEC® (imatinib mesylate) 

Novartis

2008 – ISENTRESS® (raltegravir) 

Merck & Co., Inc.

SELZENTRY® (maraviroc) 

Pfizer Inc.

2007 – CHANTIX® (varenicline) 

Pfizer Inc.

JANUVIA® (sitagliptin) 

Merck & Co., Inc.

Best Biotechnology Product Category

2015 – KEYTRUDA® (pembrolizumab) 

Merck & Co., Inc.

OPDIVO® (nivolumab) 

Bristol-Myers Squibb Company

2014 – HEMACORD® (HPC, Cord Blood) 

NY Blood Center's Howard P. Milstein Cord Blood Center

2013 – ZOSTAVAX® (Zoster Vaccine Live) 

Merck & Co., Inc.

2012 – YERVOY® (ipilimumab) 

Bristol-Myers Squibb Company

2011 – PROLIA® and XGEVA® (denosumab) 

Amgen Inc.

STELARA® (ustekinumab) 

Janssen

2010 – ROTATEQ® (Rotavirus Vaccine) 

Merck & Co., Inc.

2009 – Nplate® (romiplostim) 

Amgen Inc.

PROMACTA® (eltrombopag) 

Novartis (originally GSK)

2008 – INFUSE® 

Pfizer Inc.

REVLIMID® (lenalidomide) 

Celgene Corporation

SOLIRIS® (eculizumab) 

Alexion Pharmaceuticals, Inc.

2007 – GARDASIL® 

Merck & Co., Inc.

HUMIRA® (adalimumab) 

AbbVie [Abbott]

Best Medical Technology Category

2015 – T2Candida® Panel 

T2 Biosystems®

2014 – TREVO® XP ProVue Retriever 

Stryker

2013 – S-ICD System ™ 

Boston Scientific Corporation

2012 – MELODY ™ Transcatheter Pulmonary Valve 

Medtronic

SAPIEN ™ 

Edwards Lifesciences Corporation

2010 – xTAG® 

Luminex®

2009 – CELLSEARCH® 

Janssen Diagnostics, LLC

Bruno Cohen, Chairman of the Galien Foundation, points out to the inclusion of medical devices and related technologies in the Discovery of the Decade Awards beginning in 2009. "The Foundation recognizes that innovation that impacts human life takes varied forms. Whether tablet, biologic or technology, improving patient quality of life is a shared priority. Our objective is to demonstrate the positive health impact over time of many forms of innovation." 

The three recipients of the Discovery of the Decade awards are determined independently by the Prix Galien USA Committee based on a single criterion – their record and potential for impacting human health. Product sales data are not considered by the Committee in its decisions, nor are there any financial or promotional inducements permitted from candidates and their representatives.

Registration to attend the 2016 Ceremony can be accessed here.

Galien Awards Committee 2016

Pr Richard Axel, M.D., Nobel Laureate, Co-director, the Kavli Institute for Brain Science, Columbia University Medical Center, New York
Pr Michael S. Brown, M.D., Nobel Laureate, Professor of Molecular Genetics and Internal Medicine, UT Southwestern Medical Center, Dallas, TX
Pr Laurie Glimcher, M.D., CEO and President, Dana Farber Cancer Institute, Professor of Medicine, Harvard Medical School
Pr Joseph Goldstein, M.D., Nobel Laureate, Professor of Molecular Genetics and Internal Medicine, UT, Southwestern Medical Center, Dallas, TX
Pr Robert S. Langer, M.D., David H. Koch Institute Professor at MIT
Pr Paul A. Marks, M.D., Laboratory Head of Cell Biology Memorial Sloan-Kettering Cancer Center, New York , President, Emeritus, MSKCC
Pr Bengt Samuelsson, M.D., Ph.D., Nobel Laureate, Former President of Karolinska Institute and Former Chairman of the Nobel Foundation
Pr Marc Tessier-Lavigne, Ph.D., President, Stanford University, Stanford, CA
Pr Roy Vagelos, M.D., Chairman, Prix Galien Committee, Chairman of Regeneron Pharmaceuticals, inc. and Retired Chairman and Chief Executive Officer of Merck & Co., Inc.

About the Galien Foundation

The Galien Foundation fosters, recognizes and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatment and technologies that will impact human health and save lives.

The Foundation oversees and directs activities in the USA for the Prix Galien, an international award that recognizes outstanding achievements in improving the human condition through the development of innovative therapies. The Prix Galien was created in France in 1970 in honor of Galen, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical and medical technology research.

The Galien Foundation and the Awards Committee mourns the loss of its Honorary Member, Pr. Elie Wiesel, Peace Nobel Laureate, Boston University Professor Emeritus, who passed away on July 2, 2016.

For more information, visit www.galienfoundation.org 
Galien Foundation Media Contacts

Mr. Lee Davies/Biopharmaceutical categories
Makovsky 
[email protected] 
212-508-9651

Ms. Kristen Berry/Medical Technologies category 
Finn Partners
[email protected] 
774-573-0455

SOURCE The Galien Foundation

Related Links

http://www.galienfoundation.org

Modal title

Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2022 Cision US Inc.